AsburyA.K.: Diagnostic considerations in Guillain-Barré syndrome. Ann. Neurol.9 (Suppl): 1–5, 1981.
2.
HughesR.A.C., KadlubowskiM., HufschmidtA.: Treatment of acute inflammatory polyneuropathy. Ann. Neurol.9 (Suppl.): 125–133, 1981.
3.
CookS.D., DowlingP.C.: The role of autoantibody and immune complexes in the pathogenesis of Guillain-Barré Syndrome. Ann. Neurol.9 (Suppl.): 70–79, 1981.
4.
BrettleR.P., GrossM., LeggN.J., LockwoodM., PallisC.: Treatment of acute polyneuropathy by plasma exchange. Lancet2: 1100, 1978.
5.
CookS.D., TindallR.A.S., WalkerJ., KhanA., RosenbergR.: Plasma exchange as a treatment of acute and chronic idiopathic autoimmune polyneuropathy: Limited success. Neurol30: 361, 1980.
ReinherzE.L., WeinerH.L., HauserS.L., CohenJ.A., DistasoJ.A., SchlossmanS.F.: Loss of suppressor T cells in active multiple scloresis. N. Engl. J. Med.303: 125–129, 1980.
DauP.C.: Plasmapheresis in idiopathic inflammatory myopathy: Experience with 35 patients. Arch. Neurol.38: 544–552, 1981.
12.
DauP.C., KahalehM.D., SagebielR.W.: Plasmapheresis and immunosuppressive drug therapy in scleroderma. Arthritis Rheum.24: 1128–1136, 1981.
13.
EatonL.M.: The perspective of neurology in regard to polymyositis. Neurology (Minneap.)4: 245–263, 1954.
14.
BenningtonJ.L., DauP.C.: Patients with polymyositis and dermatomyositis who undergo plasmapheresis therapy: Pathologic findings. Arch. Neurol.38: 553–560, 1981.
15.
GoffinetD.R., GladsteinE.J., MeriganT.C.: Herpes zoster — varicella infections and lymphoma. Ann. Int. Med.76: 235–240, 1972.
16.
EatonL.M., LambertE.H.: Electromyography and electrical stimulation of nerves in disease of motor unit. JAMA116: 1117–1124, 1957.
17.
ElmquistD., LambertE.H.: Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clinic Proc.43: 689–719, 1968.
ChaoL.-P., KanS.-S.K., AngeliniC., KeeselJ.: Autoimmune neuromuscular disease induced by a preparation of choline acetyltransferase. Exp. Neurol., in press.
20.
GutmannL., CrosbyT.W., TakamoriM., MartinJ.D.: The Eaton-Lambert syndrome and autoimmune disorders. Am. J. Med.53: 354–356, 1972.
21.
StreibE.W., RothnerD.A.: Eaton-Lambert myasthenic syndrome: Long term treatment of three patients with prednisone. Ann. Neurol.7: 121–122, 1980.
22.
DauP.C., LindstromJ.M., CasselC.K., DenysE.H., ShevE.E., SpitlerL.E.: Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N. Engl. J. Med.297: 1134–1140, 1977.
23.
DauP.C., DenysE.H.: Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome. Ann. Neurol., in press.
24.
DenysE.H., DauP.C.: Neuromuscular transmission before and after plasmapheresis in myasthenia gravis and the myasthenic syndrome. In Plasmapheresis and the Immunobiology of Myasthenia Gravis.DauP.C., ed. Haughton Mifflin, Boston, 1979, pp 248–257.
25.
LindstromJ.M., DauP.C.: The biology of mysthenia gravis. Ann. Rev. Pharmacol. Toxicol.20: 337–62, 1980.
26.
LindstromJ.: An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin. Immunol. Immunopath.7: 36–43, 1977.
27.
CastelmanB.: The pathology of the thymus gland in myasthenia gravis. Ann. N.Y. Acad. Sci.135: 496–505, 1966.
28.
KeeseyJ.: Indications for thymectomy in myasthenia gravis. In Plasmapheresis and the Immunobiology of Myasthenia Gravis.DauP.C., ed. Houghton Mifflin, Boston, 1979, pp. 124–136.
29.
HowardF.M.Jr.: Myasthenia gravis with onset after 65 years of age: A preliminary report. Houghton Mifflin, Boston. pp. 281–288, 1979.
30.
DauP.C.: Plasmapheresis therapy in myasthenia gravis. Muscle and Nerve3: 468–482, 1980.
31.
DauP.C.: Response to plasmapheresis and immunosuppressive drug therapy in sitxty myasthenia gravis patients. Ann. N.Y. Acad. Sci., in press.